New Novozymes CEO

Steen Riisgaard will step down as president and CEO of Novozymes, effective 1 April. He will be replaced by Peder Holk Nielsen, who currently serves as executive v.p./enzyme business at Novozymes. Novozymes, meanwhile, reported a 9% year-on-year increase in revenue for the fourth quarter of 2012, to 2.8 billion Danish kroner ($499 million). Net profit for the quarter stood at DK493 million, 36% above the year-earlier quarter. Fourth-quarter operating profit—Ebit—rose by 35%, to DK671 million, from the same period in the previous...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers